{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-120067","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.232925+00:00","generated_at":"2026-05-16T13:39:05.643920+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"INmune Bio terminates $75M ATM sales agreement with RBC and BTIG effective Dec 19, 2025","bullets":["Company notified RBC and BTIG of termination on Dec 5 and Dec 9, 2025; effective Dec 19.","No termination penalties or expenses incurred.","Prior to termination, co. raised ~$10.5M net proceeds through sale of 1,353,469 shares.","Original agreement allowed up to $75M in at-the-market offerings since Aug 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-120067","json":"https://secwatch.observer/filing/0001213900-25-120067.json","markdown":"https://secwatch.observer/filing/0001213900-25-120067.md","text":"https://secwatch.observer/filing/0001213900-25-120067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025120067/0001213900-25-120067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025120067/ea0269071-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:39:05.643920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}